LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent manner
Advances in Clinical and Experimental Medicine · 2024
DOI: 10.17219/acem/188367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2024. Verfasst von Chaogang Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Wuhan Third Hospital (Tongren Hospital of Wuhan University), China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Methyltransferases, Thyroid Cancer, Papillary, Thyroid Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Wuhan Third Hospital (Tongren Hospital of Wuhan University), China.
- Department of General Surgery, Jianghan University, Wuhan, China.
Zitieren
APA
Huang, C., Duan, Z., Chen, B., Xia, H., & Wang, G. (2024). LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent manner. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/188367
Vancouver
Huang C, Duan Z, Chen B, Xia H, Wang G. LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent manner. Advances in Clinical and Experimental Medicine. 2024. doi:10.17219/acem/188367
BibTeX
@article{Huang2024,
author = {Huang, Chaogang and Duan, Ziqi and Chen, Baojie and Xia, Hailiang and Wang, Guangxin},
title = {LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent manner},
journal = {Advances in Clinical and Experimental Medicine},
year = {2024},
doi = {10.17219/acem/188367}
}
EUVIMED